Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
作者:
主题词
老年人(Aged);老年人, 80以上(Aged, 80 and over);动物(Animals);碱基序列(Base Sequence);结合, 竞争性(Binding, Competitive);细胞膜(Cell Membrane);DNA引物(DNA Primers);GTP结合蛋白质类(GTP-Binding Proteins);人类(Humans);动力学(Kinetics);男(雄)性(Male);分子序列数据(Molecular Sequence Data);神经肽类(Neuropeptides);神经递质药(Neurotransmitter Agents);垂体腺苷酸环化酶激活多肽(Pituitary Adenylate Cyclase-Activating Polypeptide);聚合酶链反应(Polymerase Chain Reaction);前列腺(Prostate);前列腺切除术(Prostatectomy);前列腺增生(Prostatic Hyperplasia);RNA, 信使(RNA, Messenger);放射配体测定(Radioligand Assay);大鼠(Rats);受体, 垂体腺苷酸环化酶激活多肽(Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide);受体, 垂体腺苷酸环化酶激活多肽, Ⅰ型(Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I);受体, 垂体激素(Receptors, Pituitary Hormone);受体, 血管活性肠肽(Receptors, Vasoactive Intestinal Peptide);转录, 遗传(Transcription, Genetic);血管活性肠肽(Vasoactive Intestinal Peptide)
DOI
10.1210/endo.137.7.8770902
PMID
8770902
发布时间
2015-11-19
- 浏览4

Endocrinology
2815-22页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文